Ophthalmic collagen cross-linking integrated device

Abstract

The invention discloses an ophthalmic collagen cross-linking integrated device which comprises a working device, a control device, a perfusion device, a light source device and a power supply device,wherein the power supply device is electrically connected with the working device, the infusion device, the control device and the light source device respectively, the perfusion device is connected to the working device through a conduit, the light source device and the working device are connected by light, the control device is connected with the working device, the perfusion device and the light source device by a wireless or wired manner, the devices can be fixedly connected or actively connected, and the working device is used for alignment of treatment parts, the control device is usedfor displaying and controlling the working state, the perfusion device is used for controlling the perfusion rate of a riboflavin solution, and the light source device is used for generating therapeutic light. The device is small in size, quick and convenient to carry, simple and flexible to operate, integrates ultraviolet light irradiation and riboflavin perfusion in one, not only improves the accuracy of the treatment process, but also liberates the hands of an operator, makes a treatment system more efficient and flexible.

Description

technical field [0001] The invention relates to the technical field of ophthalmic medical devices, in particular to an ophthalmic collagen cross-linking integrated equipment. Background technique [0002] As a refractory eye disease with high incidence, myopia not only manifests as abnormality of the ocular refractive system, but also can be accompanied by varying degrees of damage to the visual nervous system. It has become a disease that seriously threatens global public health. Progressive myopia, as one of them, often leads to blindness due to severe pathological changes of the fundus system, which greatly threatens human health and quality of life. [0003] During the formation and development of myopia, the main pathological manifestations are sclera thinning and axial length increase. Collagen fibers in normal sclera tissue account for about 75% of the dry weight of sclera, which makes the sclera tissue have strong toughness and plays a key role in resisting intraocu...

AI Technical Summary

Problems solved by technology

[0005] Ultraviolet light-riboflavin cross-linking is currently the most important collagen cross-linking method used in ophthalmology research. Studies have proved that this method can strengthen the biomechanical strength of cornea and sclera tissue. However, there are generally disadvantages such as large volume and cumbersome operation, and this kind of cross-linking equipment is mostly a combination of a separate probe-type irradiation device and the operator’s manual drop of riboflavin, and the riboflavin solution during the operation The accuracy of the dripping method has certain requirements, and the manual dripping of riboflavin is labor-intensive and inefficient

Images